Proton pump inhibitor treatment is associated with the severity of liver disease and increased mortality in patients with cirrhosis

Abstract

PPI use is an independent risk factor for mortality in patients with cirrhosis. Although a causative role for increased mortality in patients taking PPI is still missing, the prescription of PPI in cirrhotics should be considered carefully taking into account its potential adverse effects.